Distinct genetic control of parasite elimination, dissemination, and disease after Leishmania major infection.
Kurey, Iryna; Kobets, Tetyana; Havelková, Helena; Slapnicková, Martina; Quan, Lei; Trtková, Katerina; Grekov, Igor; Svobodová, Milena; Stassen, Alphons P; Hutson, Alan; Demant, Peter; Lipoldová, Marie.
; 61(9): 619-33, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19705113
Continual renewal and replication of persistent Leishmania major parasites in concomitantly immune hosts.
Cutaneous Manifestations of Human and Murine Leishmaniasis.
Myeloid Cell-Derived HIF-1α Promotes Control of Leishmania major.
Pink plaque on the arm of a man after a trip to Mexico: cutaneous leishmaniasis.
Lymph node hypertrophy following Leishmania major infection is dependent on TLR9.
Leishmaniasis in Turkey: first clinical isolation of Leishmania major from 18 autochthonous cases of cutaneous leishmaniasis in four geographical regions.
Transgenic expression of CXCR3 on T cells enhances susceptibility to cutaneous Leishmania major infection by inhibiting monocyte maturation and promoting a Th2 response.
American cutaneous leishmaniasis: In situ immune response of patients with recent and late lesions.
Heterogeneity of humoral immune response to Leishmania tropica in an experimental model.
Tissue damage and immunity in cutaneous leishmaniasis.